merestinib - CISMeF

Preferred Label : merestinib;

MeSH note : in phase I clinical trials (2013); structure in first source;

CISMeF synonym : LY280165; N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide;

Is substance : O;

UNII : 5OGS5K699E;

Details

Origin ID

C586252;

UMLS CUI

C4287805;

Currated CISMeF NLP mapping
- Merestinib [NCIt concept]
MeSH indexing information
- antineoplastic agents [MeSH Descriptor]
- protein kinase inhibitors [MeSH Descriptor]
MeSH term(s) associated for indexing
- indazoles [MeSH Descriptor]
- niacinamide [MeSH Descriptor]
Record concept(s)
- LY2801653 [MeSH concept]
- N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide [MeSH concept]
- merestinib [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Merestinib [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients